Literature DB >> 10993653

Identification of genes differentially expressed in association with acquired cisplatin resistance.

A Johnsson1, I Zeelenberg, Y Min, J Hilinski, C Berry, S B Howell, G Los.   

Abstract

The goal of this study was to identify genes whose mRNA levels are differentially expressed in human cells with acquired cisplatin (cDDP) resistance. Using the parental UMSCC10b head and neck carcinoma cell line and the 5.9-fold cDDP-resistant subline, UMSCC10b/Pt-S15, two suppressive subtraction hybridization (SSH) cDNA libraries were prepared. One library represented mRNAs whose levels were increased in the cDDP resistant variant (the UP library), the other one represented mRNAs whose levels were decreased in the resistant cells (the DOWN library). Arrays constructed with inserts recovered from these libraries were hybridized with SSH products to identify truly differentially expressed elements. A total of 51 cDNA fragments present in the UP library and 16 in the DOWN library met the criteria established for differential expression. The sequences of 87% of these cDNA fragments were identified in Genbank. Among the mRNAs in the UP library that were frequently isolated and that showed high levels of differential expression were cytochrome oxidase I, ribosomal protein 28S, elongation factor 1alpha, alpha-enolase, stathmin, and HSP70. The approach taken in this study permitted identification of many genes never before linked to the cDDP-resistant phenotype. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993653      PMCID: PMC2363570          DOI: 10.1054/bjoc.2000.1420

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Effects of oncogenes on the resistance to cis-diamminedichloroplatinum(II) and metallothionein gene expression.

Authors:  T Yamada-Okabe; H Yamada-Okabe; Y Kashima; R Doi
Journal:  Toxicol Appl Pharmacol       Date:  1995-08       Impact factor: 4.219

2.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Inexpensive handheld device for the construction of high-density nucleic acid arrays.

Authors:  M Schummer; W Ng; P S Nelson; R E Bumgarner; L Hood
Journal:  Biotechniques       Date:  1997-12       Impact factor: 1.993

4.  The role of DNA mismatch repair in platinum drug resistance.

Authors:  D Fink; S Nebel; S Aebi; H Zheng; B Cenni; A Nehmé; R D Christen; S B Howell
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

5.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

Authors:  W W Kuang; D A Thompson; R V Hoch; R J Weigel
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

6.  Identifying markers for pancreatic cancer by gene expression analysis.

Authors:  W Zhou; L J Sokoll; D J Bruzek; L Zhang; V E Velculescu; S B Goldin; R H Hruban; S E Kern; S R Hamilton; D W Chan; B Vogelstein; K W Kinzler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-02       Impact factor: 4.254

7.  Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.

Authors:  H Miyake; N Hanada; H Nakamura; S Kagawa; T Fujiwara; I Hara; H Eto; K Gohji; S Arakawa; S Kamidono; H Saya
Journal:  Oncogene       Date:  1998-02-19       Impact factor: 9.867

8.  Gene expression profiles in normal and cancer cells.

Authors:  L Zhang; W Zhou; V E Velculescu; S E Kern; R H Hruban; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-05-23       Impact factor: 47.728

9.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

Authors:  C Marth; M Widschwendter; J Kaern; N P Jørgensen; G Windbichler; A G Zeimet; C Tropé; G Daxenbichler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  15 in total

1.  Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.

Authors:  Joohee Yoon; Eung-Sam Kim; Sung Jong Lee; Chang-Wook Park; Hyung Jin Cha; Bee Hak Hong; Kwan Yong Choi
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

Review 2.  Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis.

Authors:  Sarah Thornton; Nisha Anand; Dan Purcell; Jonathan Lee
Journal:  J Mol Med (Berl)       Date:  2003-08-01       Impact factor: 4.599

3.  RAD001 can reverse drug resistance of SGC7901/DDP cells.

Authors:  Liu Ying; Zhu Zu-An; Liu Qing-Hua; Kong Qing-Yan; Liu Lei; Cui Tao; Wu Yong-Ping
Journal:  Tumour Biol       Date:  2014-06-12

4.  HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.

Authors:  Huajie Song; Jianqun Wang; Xiaojing Wang; Boling Yuan; Dan Li; Anpei Hu; Yanhua Guo; Shuang Cai; Shikai Jin; Yi Zhou; Qilan Li; Guo Chen; Haiyang Gao; Liduan Zheng; Qiangsong Tong
Journal:  Oncogene       Date:  2022-03-22       Impact factor: 9.867

5.  iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells.

Authors:  Huai-Dong Hu; Feng Ye; Da-Zhi Zhang; Peng Hu; Hong Ren; Sang-Lin Li
Journal:  J Biomed Biotechnol       Date:  2010-06-06

6.  Identification of a novel binding protein of FAT10: eukaryotic translation elongation factor 1A1.

Authors:  Xin Yu; Xiuxia Liu; Tiande Liu; Kui Hong; Jun Lei; Rongfa Yuan; Jianghua Shao
Journal:  Dig Dis Sci       Date:  2012-05-09       Impact factor: 3.199

7.  Identification and characteristics of a novel gene, EJO1, in the Chinese mitten crab (Eriocheir japonica sinensis) ovary.

Authors:  ChangYan Ma; YuJie Guo; KaiYa Zhou
Journal:  Mol Biol Rep       Date:  2009-09-02       Impact factor: 2.316

8.  Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity.

Authors:  Alvaro Blanch; Fiona Robinson; Ian R Watson; Lynn S Cheng; Meredith S Irwin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Networking of differentially expressed genes in human cancer cells resistant to methotrexate.

Authors:  Elisabet Selga; Carlota Oleaga; Sara Ramírez; M Cristina de Almagro; Véronique Noé; Carlos J Ciudad
Journal:  Genome Med       Date:  2009-09-04       Impact factor: 11.117

Review 10.  The role of protein elongation factor eEF1A2 in ovarian cancer.

Authors:  Jonathan M Lee
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.